Form 4 Tracker
ICU MEDICAL INC/DE
ICUI

28 insider filings · Latest: Sep 3, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Sep 3, 2026Sep 3 10:29 PMVirginia Ruth SanzoneVP, General Counsel
Sale
4,856$168.69$819.2K14,604(D)

View →

Sep 3, 2026Sep 3 8:02 PMVIRGINIA SANZONE
Proposed Sale
4,856$168.69$819.2K—

View →

Sep 1, 2026Sep 1 9:21 PMBrian Michael BonnellChief Financial Officer
Sale
6,381$175.00$1.1M56,062(D)

View →

Sep 1, 2026Sep 1 8:07 PMBRIAN BONNELL
Proposed Sale
6,381$175.00$1.1M—

View →

Aug 31, 2026Aug 31 8:43 PMBrian Michael BonnellChief Financial Officer
Sale
9,307$172.79$1.6M62,443(D)

View →

Aug 31, 2026Aug 31 8:13 PMBRIAN BONNELL
Proposed Sale
9,307$172.79$1.6M—

View →

Aug 13, 2026Aug 13 10:56 PMDaniel WoolsonVP, GM-Infusion Capital
Sale
5,417$181.33$982.3K17,062(D)

View →

Aug 13, 2026Aug 13 8:17 PMDANIEL WOOLSON
Proposed Sale
5,417$181.33$982.3K—

View →

Aug 12, 2026Aug 12 8:33 PMBen SousaChief Information Officer
Sale
2,250$178.32$401.2K3,076(D)

View →

Aug 12, 2026Aug 12 8:24 PMBENJAMIN SOUSA
Proposed Sale
2,250$178.32$401.2K—

View →

Aug 11, 2026Aug 11 10:18 PMChristian B. VoigtlanderChief Operating Officer
Sale
8,929$182.93$1.6M37,377(D)

View →

Aug 11, 2026Aug 11 9:59 PMElisha W FinneyDirector
Sale
378$182.48$69.0K4,871(D)

View →

Aug 11, 2026Aug 11 8:32 PMCHRISTIAN VOIGTLANDER
Proposed Sale
8,929$182.93$1.6M—

View →

Aug 11, 2026Aug 11 8:11 PMELISHA W FINNEY
Proposed Sale
378$182.48$69.0K—

View →

May 22, 2026May 22 8:35 PMDANIEL WOOLSON
Proposed Sale
2,123$132.21$280.7K—

View →

May 22, 2026May 22 7:47 PMDaniel WoolsonPresident
Sale
2,123$132.21$280.7K22,479(D)

View →

May 14, 2026May 15 4:19 PMVirginia Ruth SanzoneVP, General Counsel
Sale
2,447$124.08$303.6K19,460(D)

View →

May 14, 2026May 14 10:48 PMVIRGINIA SANZONE
Proposed Sale
2,447$124.08$303.6K—

View →

May 12, 2026May 14 12:31 AMDavid C. GreenbergDirector
Sale
2,424$122.91$297.9K7,960(D)

View →

May 12, 2026May 12 9:39 PMDAVID C GREENBERG
Proposed Sale
2,424$122.91$297.9K—

View →

Page 1 of 2

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 13, 2026May 14 1:29 AMKolleen T KennedyDirector
Option Exercise
1,254—0(D)

View →

May 13, 2026May 14 1:29 AMKolleen T KennedyDirector
Grant/Award
1,475—1,475(D)

View →

May 13, 2026May 14 1:20 AMLaurie HernandezDirector
Grant/Award
1,475—1,475(D)

View →

May 13, 2026May 14 1:20 AMLaurie HernandezDirector
Option Exercise
1,254—0(D)

View →

May 13, 2026May 14 1:11 AMElisha W FinneyDirector
Option Exercise
1,254—0(D)

View →

May 13, 2026May 14 1:11 AMElisha W FinneyDirector
Grant/Award
1,475—1,475(D)

View →

May 13, 2026May 14 12:52 AMDonald AbbeyDirector
Grant/Award
1,475—1,475(D)

View →

May 13, 2026May 14 12:52 AMDonald AbbeyDirector
Option Exercise
1,254—0(D)

View →

May 13, 2026May 14 12:38 AMDavid F HoffmeisterDirector
Grant/Award
1,475—1,475(D)

View →

May 13, 2026May 14 12:38 AMDavid F HoffmeisterDirector
Option Exercise
1,254—0(D)

View →

May 13, 2026May 14 12:31 AMDavid C. GreenbergDirector
Option Exercise
1,254—0(D)

View →

May 13, 2026May 14 12:31 AMDavid C. GreenbergDirector
Grant/Award
1,475—1,475(D)

View →

May 12, 2026May 14 12:31 AMDavid C. GreenbergDirector
Option Exercise
2,424$101.060(D)

View →

Mar 15, 2026Mar 16 8:34 PMChristian B. VoigtlanderChief Operating Officer
Option Exercise
14,648—0(D)

View →

Mar 15, 2026Mar 16 8:33 PMDaniel WoolsonVP, GM-Infusion Capital
Option Exercise
2,924—0(D)

View →

Mar 15, 2026Mar 16 8:32 PMBen SousaChief Information Officer
Option Exercise
1,300—0(D)

View →

Mar 15, 2026Mar 16 8:31 PMVirginia Ruth SanzoneVP, General Counsel
Option Exercise
7,324—0(D)

View →

Mar 15, 2026Mar 16 8:30 PMVivek JainDirector, Chairman and CEO
Option Exercise
21,972—0(D)

View →

Mar 15, 2026Mar 16 8:28 PMBrian Michael BonnellChief Financial Officer
Option Exercise
14,648—0(D)

View →

Mar 8, 2026Mar 9 8:32 PMBrian Michael BonnellChief Financial Officer
Option Exercise
71,757—0(D)

View →

Page 1 of 2

Next →